Saturday, February 11, 2017 9:05:46 AM
Listen, I respect your position. I still believe in the treatment, that is why I still hold shares, but I am concerned that the next round of financing will be for CAN .10 w/warrants and I just think the CEO talking about THAT would be nice.
Anyone that knows anything about clinical trials should have already known the info in the interview - as they said, if you didn't you shouldn't be investing on your own. How about giving us some info we don't know - like where future funding is going to come from? I don't see things progressing quickly enough not to need another cash infusion or two...or three....before we get to partnership talk.
I could be wrong, I hope I am - but I think for everyone on this board THAT would be a much more valuable conversation than what the interview dealt with --- '
Following the charts is like driving a car forward while looking in the rear view mirror.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM